SEC Form 4 · accession 0001106578-26-000137
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Sep 8, 2026
Accepted (ET)
Sep 9, 2026 · 4:33 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 8, 2026 | M | 9,500 | $117.76 | A | 333,943 | I | by Trust |
| Common StockF3,F2 | Sep 8, 2026 | S | 40 | $481.9118 | D | 333,903 | I | by Trust |
| Common StockF4,F2 | Sep 8, 2026 | S | 200 | $483.90 | D | 333,703 | I | by Trust |
| Common StockF5,F2 | Sep 8, 2026 | S | 220 | $491.0382 | D | 333,483 | I | by Trust |
| Common StockF6,F2 | Sep 8, 2026 | S | 140 | $492.7163 | D | 333,343 | I | by Trust |
| Common StockF7,F2 | Sep 8, 2026 | S | 144 | $493.9821 | D | 333,199 | I | by Trust |
| Common StockF8,F2 | Sep 8, 2026 | S | 600 | $494.8724 | D | 332,599 | I | by Trust |
| Common StockF9,F2 | Sep 8, 2026 | S | 256 | $495.7508 | D | 332,343 | I | by Trust |
| Common StockF10,F2 | Sep 8, 2026 | S | 300 | $497.0502 | D | 332,043 | I | by Trust |
| Common StockF11,F2 | Sep 8, 2026 | S | 1,902 | $498.1762 | D | 330,141 | I | by Trust |
| Common StockF12,F2 | Sep 8, 2026 | S | 1,018 | $498.7683 | D | 329,123 | I | by Trust |
| Common StockF13,F2 | Sep 8, 2026 | S | 1,173 | $500.1991 | D | 327,950 | I | by Trust |
| Common StockF14,F2 | Sep 8, 2026 | S | 1,221 | $501.1745 | D | 326,729 | I | by Trust |
| Common StockF15,F2 | Sep 8, 2026 | S | 1,167 | $502.2578 | D | 325,562 | I | by Trust |
| Common StockF16,F2 | Sep 8, 2026 | S | 701 | $503.3282 | D | 324,861 | I | by Trust |
| Common StockF17,F2 | Sep 8, 2026 | S | 418 | $504.1467 | D | 324,443 | I | by Trust |
| Common Stock | holding | — | — | — | 40,513 | D | ||
| Common Stock | holding | — | — | — | 166 | I | by Spouse | |
| Common StockF18 | holding | — | — | — | 249,108 | I | by Trust | |
| Common StockF19 | holding | — | — | — | 45,596 | I | by Trust | |
| Common StockF20 | holding | — | — | — | 8,902 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF22,F21 | $117.76 | Sep 8, 2026 | M | 9,500 | D | — | Mar 15, 2027 | Common Stock | 9,500 | 480,410 | I |
Explanation of responses
- F1This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10This transaction was executed in multiple trades at prices ranging from $496.55 to $497.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11This transaction was executed in multiple trades at prices ranging from $497.55 to $498.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12This transaction was executed in multiple trades at prices ranging from $498.58 to $499.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13This transaction was executed in multiple trades at prices ranging from $499.66 to $500.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14This transaction was executed in multiple trades at prices ranging from $500.67 to $501.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15This transaction was executed in multiple trades at prices ranging from $501.78 to $502.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16This transaction was executed in multiple trades at prices ranging from $502.83 to $503.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F17This transaction was executed in multiple trades at prices ranging from $503.83 to $504.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F18Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F19Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F2Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F20Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F21These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F22Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F3This transaction was executed in multiple trades at prices ranging from $481.61 to $482.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $483.87 to $483.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $490.89 to $491.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $492.03 to $492.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $493.46 to $494.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $494.48 to $495.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $495.50 to $496.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.